Cargando…
COVID-19 vaccination associated severe immune thrombocytopenia
BACKGROUND: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its identification in December 2019 in Wuhan, China resulting in more than three million deaths worldwide. Recently FDA issued emergency authoriz...
Autores principales: | Shah, Syed Raza Ali, Dolkar, Sherpa, Mathew, Jacob, Vishnu, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280588/ https://www.ncbi.nlm.nih.gov/pubmed/34266487 http://dx.doi.org/10.1186/s40164-021-00235-0 |
Ejemplares similares
-
Immune Thrombocytopenia following COVID-19 Vaccine
por: Prasad, Sonal, et al.
Publicado: (2022) -
Severe immune thrombocytopenia following COVID-19 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022) -
Immune thrombocytopenia purpura flare post COVID-19 vaccine
por: Ali, Elrazi, et al.
Publicado: (2021) -
Delayed onset of severe immune thrombocytopenia associated with COVID-19 pneumonia
por: Sato, Shintaro, et al.
Publicado: (2021) -
COVID-19 vaccination associated severe immune thrombocytopenia: A case report
por: Mousdi, M., et al.
Publicado: (2022)